[#DIV28SUPER] Assessing early career investigators career development interest

Hello Colleagues,

Please see the professional development request for information below. Please refer questions to Dr. Johannes Thrul (jthrul@jhu.edu) directly.


From: Johannes Thrul <jthrul@jhu.edu>

Dear colleagues,


We are submitting an R25 grant proposal to fund a training workshop on skills for early-career PIs in substance use and addiction research. The 3-day workshop will focus on advanced research methods, leadership and managerial skills, and resiliency.


If funded, it would be offered at no cost to participants.


The R25 applicants are Dr. Johannes Thrul (Johns Hopkins Bloomberg School of Public Health) and Dr. William Pirl (Dana-Farber Cancer Institute).


The purpose of this 1 minute survey is to collect information on level of interest among early career faculty. 




Thank you and looking forward to your feedback!






Johannes Thrul, PhD (he/him/his)

Assistant Professor

Department of Mental Health

Johns Hopkins Bloomberg School of Public Health





[#DIV28SUPER] Notice of NIH Blueprint MedTech program

 New NIH MedTech program aims to accelerate medical devices to treat, diagnose nervous system disorders


Artistic representation of human head in profile with gear symbol. Text: Blueprint MedTech

Incubator hubs will provide subawards to technology innovation teams

The National Institutes of Health, through its Blueprint MedTech program, has established two incubator hubs and launched a funding solicitation in support of commercially viable, clinically focused neurotechnology solutions to diagnose and treat disorders of the nervous system. Blueprint MedTech relies on the collaborative framework of the NIH Blueprint for Neuroscience Research, which includes the NIH Office of the Director and 12 NIH institutes and centers that support research on the nervous system.

Two incubator hubs for the program—the Center for Innovative NeuroTech Advancement (CINTA) and NeuroTech Harbor (NTH)—competed successfully to become technology accelerators for the program. CINTA is a component of the Consortia for Improving Medicine with Innovation and Technology (CIMIT), a network of academic and medical institutions, based in Boston. NTH is a collaboration among scientists, engineers, and clinicians from Johns Hopkins University, Baltimore, and Howard University, Washington, D.C.

CINTA and NTH have launched a funding opportunity on behalf of the NIH program. This program will catalyze the translation of novel neurotechnologies from early-stage development to first-in-human clinical studies. 

Read the full funding announcement here. For more information, read the NIBIB Science Highlight.


[#DIV28SUPER] Assistant Professor Opening at Texas State University

Hi all,


Please see below for details about an Assistant Professor job opening at Texas State University, starting in the fall of 2023:


The Department of Psychology at Texas State University invites applications for a tenure-track Assistant Professor position in clinical psychology. We strongly encourage applications from those who will contribute to the diversity of our community.

The successful candidate will be expected to: 1) develop and maintain an active research program that incorporates both undergraduate and graduate students; 2) teach undergraduate and graduate-level courses relevant to clinical psychology; 3) supervise Master’s theses; 4) actively seek and maintain external funding; and 5) participate in service as a good departmental citizen.

Founded in 1899, Texas State University is among the largest universities in Texas with an enrollment of 37,812 students. Designated an Emerging Research University by the State of Texas, Texas State is classified under “Doctoral Universities: Higher Research Activity,” the second-highest designation for research institutions under the Carnegie classification system. Texas State University is also designated as a Hispanic Serving Institution (HSI) and is an Equal Opportunity/Affirmative Action Employer. More than 50% of our students are persons of color, and we serve a significant number of first-generation college students. The psychology department possesses a strong commitment to diversity and multiculturalism. Thus, the department is particularly interested in candidates who have demonstrated a commitment to improving access to higher education and mentoring underrepresented students. All positions are subject to availability of funds.



  1. Doctorate in clinical psychology or a closely related discipline by the time of appointment.
  2. Scholarship productivity and record of excellence in scholarly publications (evaluated in relation to time of completion of the doctoral degree).
  3. Evidence of, or potential for, incorporating students into the research program.
  4. Demonstrated commitment to diversity and cultural sensitivity.


  1. Specialization in child/adolescent psychology or neuropsychology (although all specializations in clinical psychology will be considered).
  2. Evidence of, or potential for, securing external research funding.
  3. Quality collegiate teaching experience.
  4. Licensed or license eligible.



On-line submission of all application materials is required through the university’s application portal, https://jobs.hr.txstate.edu/postings/39869.

To assure full consideration, please submit the following by October 15, 2022:
1) Cover letter; 2) current curriculum vitae; 3) statement addressing applicant’s qualifications and research interests; 4) two/three representative publications; 5) statement of teaching philosophy; 6) evidence of teaching effectiveness; 7) diversity statement, which should include the applicant’s interpretation of diversity as well as describe the applicant’s skills, experience, and commitment to working toward achieving equity and enhancing diversity; 8) unofficial transcripts; and 9) three letters of reference.

Note that as part of our application process, we are requesting three letters of reference. Please provide the names and email addresses for your references in the Reference Letter section of the employment application. Upon submission of your application, an automated email will be generated and sent to your references with instructions on how to attach the reference letter to your application though a confidential online portal.

The selected candidate will be required to submit official transcripts from all degree-granting institutions.

Questions about the application process should be submitted via email to psychology-jobs@txstate.edu.



Ty S. Schepis, Ph.D. (he/him/his)

Professor, Department of Psychology

Texas State University


Affiliated Faculty, Center for Drugs, Smoking, and Health

School of Nursing, University of Michigan


601 University Drive, San Marcos, Texas 78666

Phone: 512-245-6805; fax: 512-245-3153



[#DIV28SUPER] Opening for Tenure-Track Assistant Professor in Clinical Psychology - Wayne State University


Please see/distribute the attached job ad for an exciting position in clinical psychology, as part of the College of Liberal Arts at Wayne State University.



Scott E. Bowen, PhD

Professor and Chair

Psi Chi, Co Advisor

Department of Psychology

Wayne State University

5057 Woodward Ave., Suite 7906.1

Detroit, MI 48202|(313) 577-2803




[#DIV28SUPER] Become a Journal of Addiction Medicine Editorial Fellow- (Due Oct 21)

The Journal of Addiction Medicine (JAM), the official peer-reviewed journal of the American Society of Addiction Medicine, seeks Editorial Fellows. Applicants should have at least two years of addiction research experience, have an MD, PhD, DSc, or PsyD degree, have completed clinical specialty training, hold faculty positions at the instructor, or assistant professor level or other junior faculty level equivalent, and have published at least 3, peer-reviewed articles. Fellows will obtain extensive experience in manuscript review and scientific peer-reviewed publishing in addiction medicine. Candidates with expertise in epidemiology/ pharmacoepidemiology, child and adolescent psychiatry, or qualitative analysis/mixed methods are encouraged to apply. The two-year Editorial Fellowship offers an annual $500 stipend. 

Application deadline: October 21, 2022. 

Click here to read the full job description: https://journals.lww.com/journaladdictionmedicine/Documents/JAM%20Fellowship%20Job%20Description%202023-2024%20FINAL.pdf

Apply online here: https://asam.users.membersuite.com/community/competitions/competition-details/e9d4de36-00aa-ceb7-0070-0b4469a6be5a

Co-editor, Journal of Addiction Medicine

Kelly E. Dunn, Ph.D., MBA

Associate Professor | Psychiatry and Behavioral Sciences
School of Medicine
Johns Hopkins University
5510 Nathan Shock Dr, Baltimore, MD 21224
O: 410-550-2254; Email: kellydunn@jhmi.edu

Schedule a zoom meeting with me directly: https://calendly.com/kelly_dunn

[#DIV28SUPER] Open rank tenure-track (Assistant or Associate) professor position at the University of New Mexico Center on Alcohol, Substance Use, And Addictions

Dear colleagues and friends,


I am thrilled to announce a new opportunity to join us at the University of New Mexico, Center on Alcohol, Substance Use and Addictions (CASAA)! We are seeking an outstanding researcher who can contribute to the research and teaching missions in their home department in the College of Arts and Sciences (includes Psychology, Sociology, Economics; a full list of departments is located here). The specific research focus and area(s) of technical expertise should complement existing areas of strength and research interests within the home department and CASAA (http://casaa.unm.edu/)


Consideration of applications will begin immediately. For best consideration, complete applications must be received by November 15, 2022. A complete application consists of 1) a letter of interest/personal statement; 2) a comprehensive CV that clearly shows meeting the minimum doctorate requirement; 3) at least two representative reprints; 4) a teaching portfolio; and 5) the titles, names and contact information (address, phone number and email address) of at least three professional references. The position will remain open until filled. Inquiries can be directed to Matthew Pearson, Ph.D., Chair, CASAA Faculty Search Committee, drmateo@unm.edu.


Applications can be submitted at https://unm.csod.com/ux/ats/careersite/18/home/requisition/21874?c=unm





Katie Witkiewitz, PhD (she/her)

Director, Center on Alcohol, Substance Use, And Addictions (CASAA)

Distinguished Professor, Department of Psychology

University of New Mexico

MSC 03-2220

Albuquerque, NM 87131

Office/Vmail: 505-585-1686

Email: katiew@unm.edu

Book a meeting with me!


Twitter: @KatieWitkiewitz


I choose to work flexibly and often send emails outside of typical working days/hours. It is not my expectation that you read, respond, or follow-up on this email outside of your hours of work.



[#DIV28SUPER] NIDA Neuroscience Update Sept 22, 2022

Table of Contents.

I.                    2022 NIDA-NIAAA Frontiers in Addiction Research Mini-Convention Nov 1-2, 2022

II.                  Job Opening for Health Scientist Administrator (HSA) specializing in Safety Pharmacology and Toxicology at NIDA

III.                NIDA is Recruiting Health Scientist Administrator (Program Officer), GS-12/13/14 in the Chemistry Pharmacology Physiology Branch in the Division of Neuroscience and Behavior (DNB).

IV.                Elucidation and Validation of the role of Transporters in the Placenta, Lactating Mammary Gland, Developing Gut, and Blood Brain Barrier (UC2 Clinical Trial Not Allowed) RFA-HD-23-003

V.                  Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)

VI.                NIH Blueprint for Neuroscience Research: Computational Training in Neuroscience and Behavior (T90/R90 - Clinical Trial Not Allowed)

VII.              BRAIN Initiative Brain Behavioral Quantification and Synchronization funding opportunity


I.     2022 NIDA-NIAAA Frontiers in Addiction Research Mini-Convention Nov 1-2, 2022

Please mark your calendars for the annual 2022 NIDA-NIAAA Frontiers in Addiction Research Mini-Convention. The Mini-Convention will be held as a 2-day virtual meeting on November 1-2, 2022. The annual NIDA-NIAAA Mini-Convention provides a forum for the Jacob P. Waletzky Award Lecture and presentations of current topics in neuroscience and addiction research. 

The Mini-Convention also showcases research by premier early stage and junior investigators working in the fields of alcohol and substance abuse and addiction research through the Early Career Investigator Showcase (ECIS) symposium. 

Three Mini-Symposia will be presented:

    • Defining mechanisms that link sleep with Substance and Alcohol Use Disorders
    • Reprogramming Glia for Brain Recovery: A Potential Future SUD Therapy
    • Understanding human neurodevelopment amid a broader social context

The virtual event is FREE and open to the public, registration is required.

Additional information and links to the conference website can be found here.




II.             Job Opening for Health Scientist Administrator (HSA) specializing in Safety Pharmacology and Toxicology at NIDA

National Institute on Drug (NIDA), US National Institutes of Health.  The Division of Therapeutics and Medical Consequences in NIDA is seeking a Health Scientist Administrator (HSA) specializing in Safety Pharmacology and Toxicology.  The HSA would be responsible for planning and implementing our comprehensive IND-enabling Toxicology Program for potential medications to treat substance use disorders as a Contracting Officer Representative (COR) on various contracts.  The Toxicology Program supports standard Good Laboratory Practices (GLP) preclinical safety studies and specialized drug-drug interaction studies required for IND and NDA filings with the FDA in which the safety of potential medications alone and in the presence of drugs of abuse are established.  The HSA would also serve as Program Official and/or Project Scientist on related grants and cooperative agreements assigned to the Division and would participate in multidisciplinary drug development teams.  United States citizenship is required.

To inquire about applying to this job vacancy, please contact Nathan M. Appel, Ph.D. (nappel@nih.gov), Acting Chief, Medications Discovery and Toxicology Branch, Division of Therapeutics and Medical Consequences, National Institute on Drug Abuse, National Institutes of Health.


Below are the announcement links to the Health Scientist Administrator positions. Please be advised that the announcements can only be viewed at this time and the links will not be active until the announcements open on Wednesday, September 21, 2022 at 12:01am.  

Delegated Examining (Open to the Public)

 GS-12/13/14 Health Scientist Administrator (Program Officer/Scientist Review Officer)

Merit Promotion (Open to Status Candidates)

III.    NIDA is Recruiting Health Scientist Administrator (Program Officer), GS-12/13/14 in the Chemistry Pharmacology Physiology Branch in the Division of Neuroscience and Behavior (DNB).


The National Institute on Drug Abuse (NIDA) is seeking an exceptional and motivated candidate for the position of Program Officer in the Chemistry Pharmacology Physiology Branch in the Division of Neuroscience and Behavior (DNB).


DNB supports basic and clinical neuroscience and behavioral research to address the public health problem of drug use and addiction by supporting research programs that provides an understanding of the neurobiological and behavioral mechanisms of drugs of use and their consequences. The Chemistry Pharmacology Physiology Branch supports all research related to chemistry and pharmacology of drugs including structural dynamics of receptors, computer-assisted drug design, intracellular signaling mechanisms, natural product chemistry, early drug discovery of treatments for addiction, and innovative mechanisms of drug delivery. The Program Officer will be responsible for creating new research initiatives and developing and overseeing research grant portfolios that leverage emerging and innovative approaches in chemistry and pharmacology of drugs.


Applicants must possess a Ph.D. degree and have knowledge in chemistry and drug design. Knowledge in biophysical and computational approaches for drug discovery and in the neurobiology of substance use disorders is preferred as is experience in grant writing and review.


Please apply for the GS-12/13/14 HSA (Program Officer) announcement through USAjobs.gov, open between September 21 through September 30, 2022.


Delegated Examining (Open to the Public)


Merit Promotion (Open to Status Candidates)


For more information, please contact: Dr. Sam Ananthan at: sam.annthan@nih.gov




IV.          Elucidation and Validation of the role of Transporters in the Placenta, Lactating Mammary Gland, Developing Gut, and Blood Brain Barrier (UC2 Clinical Trial Not Allowed) RFA-HD-23-003


This Funding Opportunity Announcement invites applications to form Transporter Elucidation Centers (TECs) as part of a Transporter Elucidation Network (TEN). TECs funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) will address key knowledge gaps in functional transport of nutrients and drugs to the developing fetus and infant through a focus on human placenta, lactating mammary gland, and developing gut. Such projects may necessitate deorphanization and characterization of understudied transporters and functional variants. TECs funded by the National Institute of Drug Abuse (NIDA) will address knowledge gaps in the role of transporters in the blood brain barrier that transport substances and treatment agents relevant to NIDA. TECs will work together to generate knowledge and resources that will be shared with the broader research community to advance our understanding of nutrient, drug, and dietary supplement constituent transport to the developing fetus and infant.




Letter of Intent due October 30, 2022 and applications are due November 30, 2022.




V.            Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)


Funding Opportunity Purpose

This Funding Opportunity Announcement (FOA) will support transformative research to identify and validate mechanisms, signaling pathways, and therapeutic targets, for understanding and reversing the effects of an overdose and the observed toxicities caused by acute Ultra-Potent Synthetic (UPS) opioid exposure. This FOA will also support mechanistic studies of persistent or delayed pathophysiological effects after acute exposure to UPS opioids.

Interested applicants are strongly encouraged to contact the Program Officer/s listed for related queries.

Additionally, please forward this funding opportunity to colleagues and/or collaborators who might be interested.

Best regards,

Kiran Vemuri, Ph.D.

Program Officer

Division of Neurosciences and Behavioral Research

Chemistry, Pharmacology and Physiology Branch

National Institute on Drug Abuse

National Institute of Health

P: 301.435.4446



VI.          NIH Blueprint for Neuroscience Research: Computational Training in Neuroscience and Behavior (T90/R90 - Clinical Trial Not Allowed)

https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-037.html  with a submission deadline of 11/29/22


On behalf of the NIH Blueprint for Neuroscience Research, NIDA seeks grant applications that will establish research training programs in computational neuroscience and behavior for undergraduate and predoctoral level students. The training program should expose undergraduate and graduate students to a wide range of neuroscience and behavioral questions, quantitative methods, and experimental systems to ensure a strong dual foundation in clinical and quantitative science.


Applications should establish research training programs in computational neuroscience and behavior for undergraduate and predoctoral level students. The training program should provide:

·       A strong foundation in research design, methods, and analytic techniques appropriate for the conduct of computational research of neuroscience and behavior

·       The enhancement of the trainees' ability to conceptualize and think through research problems with increasing independence

·       The enhancement of the trainees' understanding of neuroscience and the relationship of their research training to health and disease

·       Experience conducting research using state-of-the-art quantitative methods as well as presenting and publishing their research findings

·       The opportunity to interact with members of the scientific community at appropriate scientific meetings and workshops, including across all funded programs in this announcement

·       Optionally, applicants may propose to develop a short-course or summer course that could be open to scientists at any stage of the career continuum

A T90/R90 application must include both components (T90 and R90). Applicants will submit a single grant application and, if selected for funding, two separate awards will be issued: an NRSA T90 (Research Training award) and a non-NRSA R90 (Research Education award), which are based on distinct research training and education-related funding authorities. Each application:

·       Must include a full-time undergraduate research training component that will combine coursework and hands-on laboratory research experience (R90)

·       Must include a full-time Ruth L. Kirschstein National Research Service Award (NRSA) institutional predoctoral training component (T90)

·       May include a full-time non-NRSA institutional predoctoral training component (R90)

·       May include a short-term research education component (e.g., short course or workshop) that may include scientists at any stage of the career continuum as participants (R90)

The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications. NIH intends to fund an estimate of 4-5 awards, corresponding to a total of $2.2M, for fiscal year 2023. The maximum project period is five years.





VII.        BRAIN Initiative Brain Behavioral Quantification and Synchronization funding opportunity


Please join us on October 24, 1:30 pm EST for a pre-application information and technical assistance webinar on the new BRAIN Initiative funding opportunity announcement (FOA) Brain Behavior Quantification and Synchronization (BBQS) (RFA-MH-22-240). This funding opportunity seeks to support the development and validation of next-generation tools, methods, and analytic approaches to precisely quantify complex behaviors and combine them with simultaneous recordings of brain activity in humans. BRAIN Initiative staff, including program officers and scientific review officers, will make a brief presentation describing the FOA's research goals, areas of special interest, preapplication Information, and technical assistance. BRAIN staff will be available for a question and answer session following the presentation. Use this link to register by October 19, 2022, but note slots are going fast! Please reach out to BRAINBBQS@od.nih.gov or lizzy.ankudowich@nih.gov with any questions regarding this funding opportunity.


The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L